VALN•globenewswire•
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
Summary
Saint-Herblain (France), November 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported consolidated financial results for the first nine months of the year, ended September 30, 2025. The condensed consolidated interim financial results are available on the Company’s website (Financial Reports – Valneva).
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 20, 2025 by globenewswire